Q2 2026 13F filing
Updated 27 days ago41 disclosed positions worth $2.2B
Full holdings
Every line item disclosed in Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | A AUPH AURINIA PHARMACEUTICALS INC | $221.4M | 13.04M | 10.05% | Added(+6.7%) |
| 2 | S SYRE SPYRE THERAPEUTICS INC | $168M | 1.89M | 7.63% | Unchanged |
| 3 | M MIRM MIRUM PHARMACEUTICALS INC | $144.7M | 1.24M | 6.57% | Unchanged |
| 4 | K KNSA KINIKSA PHARMACEUTICALS INTL | $144.5M | 2.26M | 6.56% | Unchanged |
| 5 | C CELC CELCUITY INC | $137.5M | 1.31M | 6.25% | Added(+25.2%) |
| 6 | C CORT CORCEPT THERAPEUTICS INC | $130.4M | 1.50M | 5.92% | Unchanged |
| 7 | ? N/A PTC THERAPEUTICS INC | $122.4M | 1.50M | 5.56% | Unchanged |
| 8 | G GLPGF LAKEFRONT BIOTHERAPEUTICS NV | $113.5M | 3.79M | 5.16% | Unchanged |
| 9 | C CAPR CAPRICOR THERAPEUTICS INC | $98.7M | 4.10M | 4.48% | Added(+20.6%) |
| 10 | T TARS TARSUS PHARMACEUTICALS INC | $98.7M | 1.57M | 4.48% | Added(+31.9%) |
| 11 | S SPY STATE STR SPDR S&P 500 ETF T | $91.9M | 123.0K | 4.17% | Trimmed(-26.8%) |
| 12 | A ADI ANAPTYSBIO INC | $89.8M | 1.33M | 4.08% | Unchanged |
| 13 | I IMCR IMMUNOCORE HLDGS PLC | $84.1M | 2.65M | 3.82% | Unchanged |
| 14 | C CMPS COMPASS PATHWAYS PLC | $70.8M | 5.00M | 3.21% | Added(+24.9%) |
| 15 | A ANIP ANI PHARMACEUTICALS INC | $58.6M | 707.5K | 2.66% | Unchanged |
| 16 | B BNTX BIONTECH SE | $43.7M | 470.0K | 1.99% | Unchanged |
| 17 | ? N/A COMPASS THERAPEUTICS INC | $39.4M | 17.99M | 1.79% | Added(+7.2%) |
| 18 | ? N/A PRECIGEN INC | $36.6M | 6.42M | 1.66% | Unchanged |
| 19 | V VRDN VIRIDIAN THERAPEUTICS INC | $32.9M | 1.79M | 1.50% | Unchanged |
| 20 | ? N/A NUVECTIS PHARMA INC | $28.5M | 1.55M | 1.29% | — |
| 21 | D DNTH DIANTHUS THERAPEUTICS INC | $25.8M | 264.7K | 1.17% | Unchanged |
| 22 | ? N/A FULCRUM THERAPEUTICS INC | $23.9M | 6.52M | 1.08% | — |
| 23 | A AVIR ATEA PHARMACEUTICALS INC | $22.4M | 4.81M | 1.02% | Unchanged |
| 24 | ? N/A CRESCENT BIOPHARMA INC. | $20.9M | 1.16M | 0.95% | Unchanged |
| 25 | N NNDM NANO DIMENSION LTD | $20.7M | 14.29M | 0.94% | — |
| 26 | V VIK VIKING THERAPEUTICS INC | $19.5M | 500.0K | 0.89% | Unchanged |
| 27 | N NUVB NUVATION BIO INC | $18.7M | 3.30M | 0.85% | Added(+4.8%) |
| 28 | I IDYA IDEAYA BIOSCIENCES INC | $16.8M | 450.0K | 0.76% | Unchanged |
| 29 | ? N/A GOSSAMER BIO INC | $11.5M | 17.84M | 0.52% | — |
| 30 | D DERM JOURNEY MED CORP | $11.4M | 1.61M | 0.52% | Unchanged |
| 31 | I INSM INSMED INC | $10.7M | 100.0K | 0.48% | Trimmed(-61.5%) |
| 32 | S STOK STOKE THERAPEUTICS INC | $9.8M | 300.0K | 0.45% | Trimmed(-40.0%) |
| 33 | P POR PLIANT THERAPEUTICS INC | $7M | 6.14M | 0.32% | Trimmed(-0.0%) |
| 34 | ? N/A BOUNDLESS BIO INC | $6.4M | 2.56M | 0.29% | — |
| 35 | P PPLC PMV PHARMACEUTICALS INC | $5.7M | 4.25M | 0.26% | Unchanged |
| 36 | M MRNA MODERNA INC | $3.5M | 50.0K | 0.16% | Trimmed(-50.0%) |
| 37 | W WVE WAVE LIFE SCIENCES LTD | $3.5M | 600.0K | 0.16% | Unchanged |
| 38 | H HRTX HERON THERAPEUTICS INC | $2.7M | 6.25M | 0.12% | Unchanged |
| 39 | L LENZ LENZ THERAPEUTICS INC | $2.6M | 451.1K | 0.12% | Unchanged |
| 40 | ? N/A ALTIMMUNE INC | $2M | 666.0K | 0.09% | Unchanged |
| 41 | R RCL ROCKET PHARMACEUTICALS INC | $342K | 100.0K | 0.02% | Unchanged |